BLIS TechnologiesNZSE:BLT Days Payable is 118.22 as of Mar. 2026, which is 24% below its 10-year median of 155.24. The stock has 4 warning signs investors should review. Among 702 Biotechnology companies, BLIS Technologies ranks worse than 52.42% on this metric.
The historical rank and industry rank for BLIS Technologies's Days Payable or its related term are showing as below:
NZSE:BLT'
s Days Payable Range Over the Past 10 Years
Min: 87.33 Med: 155.24 Max: 239.96
Current: 101.86
During the past 13 years, BLIS Technologies's highest Days Payable was 239.96. The lowest was 87.33. And the median was 155.24.
NZSE:BLT's Days Payable is ranked worse than 52.42% of 702
companies
in the Biotechnology industry
Industry Median: 113.1
vs NZSE:BLT: 101.86
BLIS Technologies's Days Payable
declined
from Mar. 2025 (152.89) to Mar. 2026 (118.22).
It may suggest that BLIS Technologiesaccelerated paying its suppliers.
BLIS Technologies Days Payable Related Terms
BLIS Technologies Days Payable Historical Data
* Premium members only.
The historical data trend for BLIS Technologies's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NZSE:BLT vs VRTX, REGN, ALNY: Days Payable Comparison
For the Biotechnology subindustry, BLIS Technologies's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BLIS Technologies Days Payable vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, BLIS Technologies's Days Payable distribution charts can be found below:
* The bar in red indicates where BLIS Technologies's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
BLIS Technologies's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BLIS Technologies (NZSE:BLT) has a Days Payable of 118.22 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on BLIS Technologies and its competitors. This is 24% below median its historical median of 155.24. Over the past decade, BLIS Technologies' Days Payable has ranged from 87.33 to 239.96. According to the industry distribution chart, BLIS Technologies ranks #368 out of 702 companies in the Biotechnology industry, placing it in the top 52.4%.
Is BLIS Technologies' Days Payable too high?
BLIS Technologies' current Days Payable of 118.22 is 24% below median its 10-year median of 155.24. Over the past 10 years, this metric has ranged from a low of 87.33 to a high of 239.96. The Biotechnology industry median Days Payable is 113.10. BLIS Technologies' value of 118.22 is 4.5% above this industry median. Based on the distribution chart, BLIS Technologies ranks #368 out of 702 companies in the Biotechnology industry, which is below the industry midpoint.
How does BLIS Technologies' Days Payable compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, BLIS Technologies ranks #368 out of 702 companies for Days Payable. This places BLIS Technologies in the lower half of its industry. The industry median Days Payable is 113.10. BLIS Technologies' value of 118.22 is 4.5% above this benchmark. Historically, BLIS Technologies' own Days Payable has ranged from 87.33 to 239.96 over the past decade. While the company's 10-year median is 155.24 vs. the industry median of 113.10, BLIS Technologies has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 113.10, based on 702 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BLIS Technologies's current Days Payable of 118.22 is 4.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on BLIS Technologies and its competitors. For the Biotechnology industry, the median Days Payable is 113.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BLIS Technologies's current Days Payable is 118.22, which is 24% below median its own 10-year median of 155.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BLIS Technologies stock overvalued right now?
Based on GuruFocus' analysis, BLIS Technologies (NZSE:BLT) is currently considered Modestly Undervalued. The stock's GF Value™ is NZ$0.02, compared to a current price of NZ$0.02 — trading 20% below its estimated fair value. The current Days Payable is 118.22, which is 24% below median its 10-year median of 155.24 and 4.5% above the Biotechnology industry median of 113.10. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For BLIS Technologies (NZSE:BLT), the current Days Payable is 118.22 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
BLIS Technologies Ltd is engaged in developing oral probiotics. The company markets strains of probiotic bacteria BLIS K12, BLIS Q24, and BLIS M18, which occur naturally in the oral cavity. Its product portfolio consists of probiotic serum, Teeth and gums lozenge, fresh breath lozenge, and immune lozenge. Geographically, the company derives a majority of its revenue from North America. The company also generates a small portion of revenue from Non-core business, which includes grants and interest revenue.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NZSE:BLT has been successfully added to your 